Update regarding opportunities for orthopaedic surgeons to contribute to postmarket surveillance of potential safety issues for orthopaedic medical devices marketed in the United States

Affiliations

¹ Division of Orthopedic Devices, Center for Devices and Radiological Health, Office of Device Evaluation, U.S. Food and Drug Administration, Silver Spring, MD, USA.

Editorial

Vincent J Devlin. Arthroplast Today. 2017.

. 2017 Oct 16;3(4):205-206.

doi: 10.1016/j.artd.2017.09.003. eCollection 2017 Dec.

¹ Division of Orthopedic Devices, Center for Devices and Radiological Health, Office of Device Evaluation, U.S. Food and Drug Administration, Silver Spring, MD, USA.

No abstract available

Keywords: Medical devices; Safety; U.S. Food and Drug Administration (FDA).

References

1. CDRH Mission, Vision and shared values. https://www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTo... [accessed 10.05.17]
1. Califf R.M. Benefit-risk assessments at the US Food and Drug Administration finding the balance. JAMA. 2017;317(7):693. - PubMed
1. 2014-2015 Strategic Priorities—Center for Devices and Radiologic Health. https://www.fda.gov/downloads/AboutFDA/CentersOffices/OfficeofMedicalPro... [accessed 10.05.17]
1. Faris O., Shuren J. An FDA viewpoint on unique considerations for medical-device clinical trials. New Engl J Med. 2017;376:1350. - PubMed
1. Shuren J., Califf R.M. Need for a National Evaluation System for Health Technology. JAMA. 2016;316(11):1153. - PubMed